Literature DB >> 11856438

Case report. Phaeohyphomycosis caused by Phialophora verrucosa developed in a patient with non-HIV acquired immunodeficiency syndrome.

S Ohira, K Isoda, H Hamanaka, K Takahashi, K Nishimoto, H Mizutani.   

Abstract

A 53-year-old woman had asymptomatic multiple nodules on her gluteal region for 6 months. She had a history of systemic corticosteroid treatment for Evans' syndrome. Recently she had developed an immunodeficiency condition with CD4+ cell depletion without an HIV infection and a normal serum gamma globulin level. A smear from the purulent exudate of the nodules revealed many brown-coloured hyphae, spores and few large dark-brown cells. A short, hairy, dark-brown coloured colony was cultivated on Sabouraud glucose agar. Slide culturing revealed only a Phialophora-type conidia formation, and the fungus was diagnosed as Phialophora verrucosa. Severe immunosuppressive condition (non-HIV acquired immunodeficiency syndrome) of this patients after systemic corticosteroid treatment for Evans' syndrome predisposed an opportunistic cutaneous fungal infection due to P. verrucosa. Cases with cutaneous infection due to P. verrucosa reported in Japan are summarized and discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11856438

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  3 in total

Review 1.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 2.  Generalized subcutaneous phaeohyphomycosis caused by Phialophora verrucosa: report of a case and review of literature.

Authors:  Zhongsheng Tong; Sharon C-A Chen; Liuqing Chen; Bilin Dong; Ruoyu Li; Zhimin Hu; Ping Jiang; Dongsheng Li; Yiqun Duan
Journal:  Mycopathologia       Date:  2013-02-08       Impact factor: 2.574

3.  Recalcitrant primary subcutaneous phaeohyphomycosis due to Phialophora verrucosa.

Authors:  Lu-juan Gao; Jin Yu; Duan-li Wang; Ruo-yu Li
Journal:  Mycopathologia       Date:  2012-12-21       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.